UNH — UnitedHealth Group Incorporated Common Stock (DE) stock price and chart

UNH

UnitedHealth Group Incorporated Common Stock (DE)Stock · HealthcareDow Jones 4.6% · S&P 500 0.6% · Russell 1000 0.5% · US Stock Market 0.5% · Russell 3000 0.5% · MSCI World 0.4% · MSCI ACWI 0.3% · S&P 500 Equal Weight 0.2%

$379.09-2.37%

as of market close, Sep 11, 2026

☾ AH — —

PeersMRNALLYJNJMRKABBVAMGN

Technical analysis2

Overlay lines0

Addendum charts0

VolumeDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDD

20162019202120242026

150.0200.0250.0300.0350.0400.0450.0500.0550.0600.00200.0M$379.09

2026-09-11

Price$379.09

MA20$383.68

MA50$341.27

Vol37.6M

What would $1,000 invested in UNH be worth today? →

UNH returns: By year · By month · By week · Trailing

Key stats

Price data

Price: $379.09
Change YTD: +16.39%
Next earnings: Oct 27, 2026
Market cap: 340.3B2016-09 133.3B2026-09 340.1B+155.2% over the window
Enterprise value: 392.8B
Shares outstanding: 897.6M2016-06 952.4M2026-06 897.6M-5.8% over the window
52W low: $255.97
52W high: $461.62
From 52W high: -17.88%
From 52W low: +48.10%
52W range: 60%
Beta: 0.62

Volume

Rel volume: 1.65×
30D volume: 4.5M
30D $ vol: 1.8B

Fundamentals

Sales (ttm): 450.1B2016-06 176.1B2026-06 450.1B+155.6% over the window
Sales/share: $501.482016-06 $184.902026-06 $501.48+171.2% over the window
EPS (ttm): $15.552016-06 $6.392026-06 $15.55+143.4% over the window
FCF (ttm): 23.6B2016-06 8.7B2026-06 23.6B+172.8% over the window
FCF/share: $26.312016-06 $9.092026-06 $26.31+189.5% over the window
Book value/share: $116.442016-06 $38.102026-06 $116.44+205.6% over the window
Net margin: 3.14%2016-06 3.5%2026-06 3.1%-10.6% over the window
ROE: 13.51%2016-06 17.0%2026-06 13.5%-20.7% over the window
ROA: 4.56%2016-06 5.2%2026-06 4.6%-11.8% over the window
Debt / equity: 0.66×2016-06 0.742026-06 0.66-10.1% over the window
Current ratio: 0.782016-06 0.702026-06 0.78+10.5% over the window

Growth (CAGR, ttm) · 10Y

Sales: +6.46%2025-06-30 → 2026-06-30422.8B → 450.1B (+6.5% total)+8.90%2023-06-30 → 2026-06-30348.5B → 450.1B (+29.2% total)+10.59%2021-06-30 → 2026-06-30272.1B → 450.1B (+65.4% total)+9.84%2016-06-30 → 2026-06-30176.1B → 450.1B (+155.6% total)
Net income: -33.71%2025-06-30 → 2026-06-3021.3B → 14.1B (-33.7% total)-12.54%2023-06-30 → 2026-06-3021.1B → 14.1B (-33.1% total)-0.54%2021-06-30 → 2026-06-3014.5B → 14.1B (-2.7% total)+8.62%2016-06-30 → 2026-06-306.2B → 14.1B (+128.5% total)
FCF: -6.55%2025-06-30 → 2026-06-3025.3B → 23.6B (-6.5% total)-14.80%2023-06-30 → 2026-06-3038.2B → 23.6B (-38.2% total)+4.99%2021-06-30 → 2026-06-3018.5B → 23.6B (+27.6% total)+10.56%2016-06-30 → 2026-06-308.7B → 23.6B (+172.8% total)
Shares: -0.89%2025-06-30 → 2026-06-30905.7M → 897.6M (-0.9% total)-1.04%2023-06-30 → 2026-06-30926.3M → 897.6M (-3.1% total)-0.98%2021-06-30 → 2026-06-30942.9M → 897.6M (-4.8% total)-0.59%2016-06-30 → 2026-06-30952.4M → 897.6M (-5.8% total)

Per-share growth (CAGR, ttm) · 10Y

EPS: -32.76%2025-06-30 → 2026-06-30$23.12 → $15.55 (-32.7% total)-11.38%2023-06-30 → 2026-06-30$22.35 → $15.55 (-30.4% total)+0.55%2021-06-30 → 2026-06-30$15.13 → $15.55 (+2.8% total)+9.30%2016-06-30 → 2026-06-30$6.39 → $15.55 (+143.4% total)
Sales/share: +7.42%2025-06-30 → 2026-06-30$466.85 → $501.48 (+7.4% total)+10.05%2023-06-30 → 2026-06-30$376.24 → $501.48 (+33.3% total)+11.69%2021-06-30 → 2026-06-30$288.57 → $501.48 (+73.8% total)+10.49%2016-06-30 → 2026-06-30$184.90 → $501.48 (+171.2% total)
FCF/share: -5.71%2025-06-30 → 2026-06-30$27.90 → $26.31 (-5.7% total)-13.91%2023-06-30 → 2026-06-30$41.23 → $26.31 (-36.2% total)+6.03%2021-06-30 → 2026-06-30$19.63 → $26.31 (+34.0% total)+11.22%2016-06-30 → 2026-06-30$9.09 → $26.31 (+189.5% total)
Book value/share: +4.96%2025-06-30 → 2026-06-30$110.93 → $116.44 (+5.0% total)+7.27%2023-06-30 → 2026-06-30$94.32 → $116.44 (+23.5% total)+8.80%2021-06-30 → 2026-06-30$76.38 → $116.44 (+52.4% total)+11.82%2016-06-30 → 2026-06-30$38.10 → $116.44 (+205.6% total)
Dividend/share: +5.17%2025-06-30 → 2026-06-30$8.51 → $8.95 (+5.2% total)+9.43%2023-06-30 → 2026-06-30$6.83 → $8.95 (+31.0% total)+11.47%2021-06-30 → 2026-06-30$5.20 → $8.95 (+72.1% total)+15.47%2016-06-30 → 2026-06-30$2.13 → $8.95 (+321.2% total)
Price: +7.21%2025-09-11 → 2026-09-11$353.61 → $379.09 (+7.2% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-7.52%2023-09-11 → 2026-09-11$479.38 → $379.09 (-20.9% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-1.26%2021-09-10 → 2026-09-11$403.91 → $379.09 (-6.1% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+10.99%2016-09-09 → 2026-09-11$133.62 → $379.09 (+183.7% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: +10.08%2025-09-11 → 2026-09-11$344.39 → $379.09 (+10.1% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-5.76%2023-09-11 → 2026-09-11$452.95 → $379.09 (-16.3% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+0.42%2021-09-10 → 2026-09-11$371.28 → $379.09 (+2.1% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+12.78%2016-09-09 → 2026-09-11$113.82 → $379.09 (+233.1% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 24.4×2016-09 20.342026-09 24.08+18.4% over the window
P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.: 15.7×2016-09 10.912026-09 15.69+43.8% over the window
Fwd P/E: 17.7×
P/S (ttm)Market cap ÷ TTM revenue.: 0.8×2016-09 0.742026-09 0.76+2.6% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 3.3×2016-09 3.552026-09 3.25-8.3% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 14.4×2016-09 10.242026-09 14.40+40.6% over the window
EV/EBITDA (fy): 15.1×
EV/Sales (ttm): 0.9×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 6.94%2016-06 6.5%2026-06 6.2%-4.1% over the window
Dividend yield (fwd)Indicated forward annual dividend ÷ current price — the rate the company has announced, not what was actually paid over the past year.: 2.36%
Dividend/share (fwd): $8.95
Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 897.6M ÷ 905.7M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: 0.89%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (0.89%) + dividends paid over that year ($8.1B) ÷ market_cap_at(2025-06-30) ($282.5B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: 3.76%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($1B) ÷ today's market cap ($340.3B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 0.31%2016-06 0.6%2026-06 0.3%-55.0% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $1B + TTM dividends $8.1B) ÷ today's market cap ($340.3B). Same caveat as the cash buyback yield.: 2.69%2016-06 2.1%2026-06 2.4%+13.3% over the window

Vs own 10Y history

P/E: 70th
P/OI: 71st
P/S: 11th
P/B: 10th
P/FCF: 16th

Bar = where today’s multiple sits in UNH’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · windows as of 2026-09-11

-2.37%

-5.45%

-6.53%

-5.99%

YTD

+16.39%

+12.24%

-2.33%

Financial statements

Open full UNH financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	-8.44%	-0.65%
JNJ	Johnson & Johnson	+2.31%	-0.29%
ABBV	AbbVie Inc.	+3.36%	+0.83%
MRK	Merck & Co. Inc.	+8.28%	-0.54%
TMO	Thermo Fisher Scientific Inc.	+1.13%	+1.10%
AMGN	Amgen Inc.	-8.80%	-1.34%
GILD	Gilead Sciences Inc.	+5.78%	-0.75%
ABT	Abbott Laboratories	-8.08%	-1.36%

UnitedHealth Group Incorporated Common Stock (DE) (UNH) trades at $379.09 with a live price and an interactive chart covering 41+ years of daily price history, plus key valuation metrics. ChartRow also publishes UNH’s financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full UNH financial statements →

UNH — UnitedHealth Group Incorporated Common Stock (DE) price, chart and key statistics